Jianjun He

1.6k total citations
71 papers, 1.1k citations indexed

About

Jianjun He is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Jianjun He has authored 71 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 27 papers in Molecular Biology and 20 papers in Cancer Research. Recurrent topics in Jianjun He's work include Breast Cancer Treatment Studies (16 papers), Cancer Risks and Factors (9 papers) and Advanced biosensing and bioanalysis techniques (8 papers). Jianjun He is often cited by papers focused on Breast Cancer Treatment Studies (16 papers), Cancer Risks and Factors (9 papers) and Advanced biosensing and bioanalysis techniques (8 papers). Jianjun He collaborates with scholars based in China, United States and United Kingdom. Jianjun He's co-authors include Jian‐Hui Jiang, Marcel P. Bruchez, Hongjun Ren, Claudette M. St. Croix, Maria A Missinato, Simon C. Watkins, Binjie Wang, Lydia A. Perkins, Weijun Yang and Yi Wang and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Journal of Clinical Oncology.

In The Last Decade

Jianjun He

68 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jianjun He China 18 406 217 202 172 130 71 1.1k
Richard W. Ahn United States 18 474 1.2× 230 1.1× 282 1.4× 349 2.0× 75 0.6× 33 1.4k
Yajun Liu China 17 286 0.7× 109 0.5× 181 0.9× 200 1.2× 96 0.7× 59 1.2k
Yao Jin China 19 429 1.1× 167 0.8× 95 0.5× 347 2.0× 89 0.7× 40 1.2k
Di Chen China 15 358 0.9× 412 1.9× 261 1.3× 156 0.9× 60 0.5× 38 1.2k
Hongqi Tian China 21 485 1.2× 249 1.1× 606 3.0× 155 0.9× 104 0.8× 52 1.5k
Yoshihisa Namiki Japan 19 486 1.2× 247 1.1× 137 0.7× 288 1.7× 105 0.8× 43 1.5k
Yuanming Pan China 20 599 1.5× 217 1.0× 56 0.3× 169 1.0× 130 1.0× 63 1.2k
Yimeng Du China 18 331 0.8× 106 0.5× 99 0.5× 273 1.6× 42 0.3× 45 988
David Bauer Germany 21 429 1.1× 141 0.6× 313 1.5× 258 1.5× 118 0.9× 50 1.4k
Jung Young Kim South Korea 20 253 0.6× 267 1.2× 103 0.5× 213 1.2× 182 1.4× 99 1.3k

Countries citing papers authored by Jianjun He

Since Specialization
Citations

This map shows the geographic impact of Jianjun He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianjun He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianjun He more than expected).

Fields of papers citing papers by Jianjun He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianjun He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianjun He. The network helps show where Jianjun He may publish in the future.

Co-authorship network of co-authors of Jianjun He

This figure shows the co-authorship network connecting the top 25 collaborators of Jianjun He. A scholar is included among the top collaborators of Jianjun He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianjun He. Jianjun He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Jingyi, Yidi Wang, Na Chai, et al.. (2025). Proteomic profiling reveals biological processes and biomarkers involved in the pathogenesis of occult breast cancer. BMC Cancer. 25(1). 231–231.
2.
Zhang, Huimin, et al.. (2024). Axillary lymph nodes pCR (apCR) versus breast pCR (bpCR): A meta-analysis involving 10,723 patients.. Journal of Clinical Oncology. 42(16_suppl). e12630–e12630.
3.
Xie, Peiling, et al.. (2023). Evaluation of outcome of chemotherapy for breast cancer patients older than 70 years: A SEER-based study. Frontiers in Oncology. 13. 992573–992573. 2 indexed citations
4.
Zhou, Yudong, Peiling Xie, Xiaoqian Gao, et al.. (2022). Identification of necroptosis-related subtypes and prognosis model in triple negative breast cancer. Frontiers in Immunology. 13. 964118–964118. 12 indexed citations
7.
Zhu, Lizhe, Qi Tian, Siyuan Jiang, et al.. (2021). A Novel Ferroptosis-Related Gene Signature for Overall Survival Prediction in Patients With Breast Cancer. Frontiers in Cell and Developmental Biology. 9. 670184–670184. 25 indexed citations
8.
Yu, Shibo, Lizhe Zhu, Ke Wang, et al.. (2019). Green tea consumption and risk of breast cancer. Medicine. 98(27). e16147–e16147. 26 indexed citations
9.
Wang, Xin, Jianjun He, Xuan Chen, & Qingqiang Yang. (2017). Stenting as a bridge to resection versus emergency surgery for left-sided colorectal cancer with malignant obstruction: A systematic review and meta-analysis. International Journal of Surgery. 48. 64–68. 25 indexed citations
10.
He, Jianjun, Huacheng Ning, & Ruixue Huang. (2017). Low blood lead levels and attention-deficit hyperactivity disorder in children: a systematic review and meta-analysis. Environmental Science and Pollution Research. 26(18). 17875–17884. 25 indexed citations
11.
Pratt, Christopher P., Dika Kuljis, Gregg E. Homanics, et al.. (2017). Tagging of Endogenous BK Channels with a Fluorogen-Activating Peptide Reveals β4-Mediated Control of Channel Clustering in Cerebellum. Frontiers in Cellular Neuroscience. 11. 337–337. 11 indexed citations
13.
Li, Yubin, et al.. (2014). MICROSTRUCTURE AND MECHANICAL PROPERTY OF LASER WELDED JOINT FOR HYPOEUTECTOID U-Nb ALLOY. Acta Metallurgica Sinica. 50(3). 379–386. 2 indexed citations
14.
Zheng, Shan, Qingkun Song, Yu Ren, et al.. (2013). The Characteristics of Breast Cancer Subtypes. Applied immunohistochemistry & molecular morphology. 22(5). 383–389. 6 indexed citations
15.
16.
Wang, Ke, et al.. (2011). [Establishment of a bioluminescent MDA-MB-231 cell line for in vivo imaging of human triple-negative breast cancer xenograft].. PubMed. 31(11). 1812–8. 2 indexed citations
17.
He, Jianjun, et al.. (2011). Predictive Value of Serum Bone Sialoprotein in Patients with Bone Metastasis of Non-Small Cell Lung Cancer. Onkologie. 34(11). 584–588. 12 indexed citations
18.
He, Jianjun, et al.. (2009). [Abnormal expression of beta-catenin and E-cadherin in Her2-positive breast cancer and its implications].. PubMed. 29(11). 2237–40. 2 indexed citations
19.
Wang, Ke, Qingyong Ma, Yu Ren, et al.. (2007). Geldanamycin destabilizes HER2 tyrosine kinase and suppresses Wnt/β-catenin signaling in HER2 overexpressing human breast cancer cells. Oncology Reports. 17(1). 89–96. 20 indexed citations
20.
Tang, Yi, et al.. (2006). Real-Time and High Throughput Monitoring of cAMP in Live Cells Using a Fluorescent Membrane Potential-Sensitive Dye. Assay and Drug Development Technologies. 4(4). 461–471. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026